Multiple Endocrine Neoplasia Type 1 (MEN 1)

Treatment of Children

In most cases, clinical manifestations of MEN 1 do not occur until a person reaches his or her 20s or 30s. However, at-risk children may be tested for the genetic mutation associated with MEN 1.

If genetic test results confirm the presence of the genetic mutation, specialists at Mayo Clinic may recommend that the child be screened regularly, starting between ages 10 and 15, for hyperthyroidism and other clinical expressions of the disease. Blood tests help endocrinologists and other specialists to track any changes in biochemical markers associated with the MEN 1 progression.

Treatment for patients who experience tumors and other expressions of MEN 1 in childhood are similar to adult treatments for multiple endocrine neoplasia. Children are most likely to suffer from pituitary tumors or abnormalities in parathyroid hormone (PTH) levels.

Appointments

For appointments or more information, call the Central Appointment Office at (507) 538-3270 7 a.m. to 7 p.m. Central time Monday through Thursday, 7 a.m. to 5 p.m. Friday.